“Rising Adoption of Automated Microplate Systems in Drug Discovery”
- Laboratories are increasingly adopting automated microplate systems to boost efficiency and minimize manual errors
- High-throughput screening (HTS) processes benefit significantly from automation by reducing analysis time and improving data accuracy
- Automation allows integration with robotics and software, streamlining workflow and enabling 24/7 operation
- Demand for personalized medicine and faster drug discovery timelines is fueling adoption of automated systems
- For instance, Thermo Fisher Scientific’s automated platforms are widely used in pharmaceutical labs to accelerate compound screening
